✦ LIBER ✦
Hormonal therapy in breast cancer and predominant visceral disease: effectiveness of the new oral aromatase inactivator, Aromasin® (exemestane), in advanced breast cancer patients having progressed on antiestrogens
✍ Scribed by Tedeschi, M.; Kvinnsland, S.; Jones, S.E.; Kaufmann, M.; Polli, A.; Fowst, C.; Massimini, G.
- Book ID
- 122407221
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 153 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.